Nature Cardiovascular Research Biochemistry, Genetics and Molecular Biology (miscellaneous)
Manipulation of ER–mitochondria interactions with mitofusin modulators reduces cardiac damage during myocardial infarction in mice
Abstract
Mitofusin (MFN) 1 and MFN2 are large outer mitochondrial membrane GTPases. Dimerization of MFNs on adjacent mitochondria mediates mitochondrial fusion. MFN2, but not MFN1, also resides at the endoplasmic reticulum (ER)/sarcoplasmic reticulum (SR) membrane, and dimerization of MFNs on ER/SR and mitochondria tethers the two organelles. Here we report that cell-permeable peptides that perturb MFN conformations regulate myocardial infarct size by impacting ER/SR–mitochondria interactions and Ca^2+ transfer independently of changes in mitochondrial fusion. MFN activators increase ER/SR–mitochondria proximity, promote ER/SR to mitochondria Ca^2+ transfer and exacerbate infarct size in mice, with effects dependent on MFN2, but not MFN1, and on mitochondrial calcium uniporter, which transports Ca^2+ into the mitochondrial matrix. Conversely, although ER/SR–mitochondria proximity is not affected, MFN inhibitors reduce mitochondrial Ca^2+ transfer and infarct size, even when their administration is delayed until reperfusion. These findings demonstrate the feasibility of acutely modulating ER/SR–mitochondria interactions and Ca^2+ dynamics and suggest that pharmacological MFN inhibition may provide a new therapeutic strategy to limit cardiac damage during reperfused myocardial infarction. Axelrod, Nichtová et al. show that acute pharmacological modulation of mitofusins regulates ER/SR–mitochondria calcium transfer and markedly influences myocardial infarct size in mice, independently of mitochondrial fusion. Notably, mitofusin inhibition limits cardiac injury, even when administered at reperfusion, highlighting a potential therapeutic strategy for myocardial infarction.